16 min listen
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ratings:
Length:
29 minutes
Released:
Oct 24, 2022
Format:
Podcast episode
Description
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the ongoing GLP-1 RA shortage and whether or not celebrities using these agents for weight loss is a real issue in the community as well as provide insight into their top takeaways from the ADA/KDIGO consensus report.
Released:
Oct 24, 2022
Format:
Podcast episode
Titles in the series (97)
Semaglutide 2.4 mg (Wegovy):A Turning Point for Obesity by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives